Please rotate your device

GET PROPEL

Stay Informed

    Stay informed

    Sign up for the PROPEL mailing list

    Provide some basic information and we’ll send you relevant content and event reminders.




    • ENT/Rhinologist
    • Other

    *ALL FIELDS REQUIRED

    By providing the above information, you agree to allow Intersect ENT to provide you with information relating to Intersect ENT’s products. The information you submit will be governed by our Privacy Policy.

      GET PROPEL

      SIGN UP TO GET PROPEL

      Empower your practice with PROPEL. Provide some basic information to connect to a representative.




      • ENT/Rhinologist
      • Other

      *ALL FIELDS REQUIRED

      By providing the above information, you agree to allow Intersect ENT to provide you with information relating to Intersect ENT’s products. The information you submit will be governed by our Privacy Policy.

      You are leaving the HCP website

      You are being directed to a third-party website. Please note that this third-party website is not controlled by PROPELOpens.com.

      Thank you for visiting our site.

      Continue

      Sinus surgery is only part of the battle.

      Add PROPEL to your

      ACTION PLAN

      For adult patients with chronic rhinosinusitis (CRS) following ethmoid, frontal, or maxillary sinus surgery

      STRENGTHEN YOUR SINUS SURGERY ARMAMENTARIUM WITH THE PROPEL FAMILY OF IMPLANTS

      WATCH VIDEO
      learn more learn more learn more

      MAXILLARY
      SINUS

      FRONTAL
      SINUS

      ETHMOID
      SINUS

      ethmoid sinus

      PROPEL

      frontal sinus ethmoid sinus

      PROPEL MINI

      frontal sinus maxillary sinus

      PROPEL
      CONTOUR

      STRENGTHEN YOUR SINUS SURGERY ARMAMENTARIUM WITH THE PROPEL FAMILY OF IMPLANTS

      WATCH VIDEO

      s

      Arm yourself to maintain sinus patency and reduce:

      • postoperative interventions
      • frank polyposis
      • occlusion/restenosis
      • inflammation

      Patients with CRS may benefit from postoperative care that reduces inflammation, in order to achieve improved sinus surgery outcomes

      LEARN MORE

      STRENGTHEN YOUR SINUS SURGERY ARMAMENTARIUM WITH THE PROPEL FAMILY OF IMPLANTS

      LEARN MORE

      6 REASONS TO ADD THE PROPEL FAMILY OF IMPLANTS TO YOUR SINUS SURGERY PLAN

      LEARN MORE

      Resources and Downloads

      The following resources may be helpful to further educate yourself about PROPEL and how to implement PROPEL into your practice

      LEARN MORE

      Stay Informed

      Sign up for the PROPEL mailing list

      SIGN UP

      GET PROPEL

      Stay Informed

      This site is intended for healthcare professionals in the United States

      Instructions for Use:

      PROPEL PROPEL MINI PROPEL Contour

      Instructions for Use (EU):

      PROPEL PROPEL MINI
      Stay Informed

      References

      1. PROPEL [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2013.
      2. PROPEL Mini [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2016.
      3. PROPEL Contour [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2016.

      The PROPEL sinus implants are indicated to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age after sinus surgery: PROPEL for the ethmoid sinus, PROPEL Mini for the ethmoid sinus/frontal sinus opening, and PROPEL Contour for the frontal/maxillary sinus ostia. Contraindications include patients with intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For full prescribing information see IFU at www.IntersectENT.com/technologies/. Rx only.

      INTERSECT ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries.

      The above-identified implants, delivery systems, and/or the use of the above-identified implants/delivery systems in a method may be covered by one or more U.S. and/foreign patents, found at intersectent.com/patents.

      ©2020 Intersect ENT, Inc. All rights reserved. MPM-11549 Rev 2.0